Will organ-on-a-chip technology be the future of drug discovery?
A recent article discusses advancements in organ-on-a-chip technology and how this technology would revolutionize drug development....
Contributors
-
Joint Head of Behavioural Science -
Account Manager -
-
Associate Consultant -
-
Joint Head of Behavioural Science -
President, USA -
Vice President, Business Development -
Senior Consultant -
-
Publications Executive -
Project Director -
-
Strategic Communications Director -
Associate Consultant -
Executive Chairman -
Consultant -
-
CEO -
-
Senior Consultant -
Consultant -
Senior Consultant -
-
SVP -
Master Practitioner: Patient Insights -
Publications Assistant -
EVP, Oncology Practice Head -
EVP, Patient Solutions -
-
US CEO -
-
Associate Editorial Director
-
Sr. Research Analyst -
-
Principal -
Research Executive -
Account Director -
-
-
Head of MedErgy (CH-MedErgy) -
-
Managing Consultant -
Project Manager -
Project Director -
Executive Vice President, Strategic Collaborations -
Associate Consultant
Cello Health Archive
- August 2021 (2)
- July 2021 (2)
- April 2021 (3)
- March 2021 (4)
- January 2021 (1)
- December 2020 (1)
- November 2020 (1)
- October 2020 (2)
- September 2020 (3)
- August 2020 (6)
- July 2020 (3)
- June 2020 (1)
- May 2020 (1)
- April 2020 (2)
- March 2020 (6)
- February 2020 (19)
- January 2020 (4)
- December 2019 (3)
- November 2019 (4)
- October 2019 (1)
- September 2019 (2)
- August 2019 (4)
- July 2019 (4)
- June 2019 (4)
- May 2019 (12)
- April 2019 (11)
- March 2019 (5)
- February 2019 (12)
- January 2019 (1)
- October 2018 (2)
- August 2018 (5)
- July 2018 (7)
- June 2018 (5)
- May 2018 (5)
- April 2018 (6)
- March 2018 (9)
- February 2018 (11)
- January 2018 (4)
- December 2017 (8)
- November 2017 (21)
- October 2017 (35)
- September 2017 (18)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (2)
- April 2017 (2)
- March 2017 (1)
- February 2017 (2)
- January 2017 (1)
- December 2016 (1)
- October 2016 (1)
Using ingestion to deliver CRISPR gene-editing tools
With the use of CRISPR/Cas9 becoming more and more prevalent in gene therapies and research, much focus has turned toward how to deliver...
Great communication for greater patient outcomes
There are few that would dismiss the value of great doctor-patient communication. Effective communication is central in building an...
Gene therapy now a reality, but how do you pay for it?
Having followed the development of gene therapy over the past 15 years, I am excited to see it coming of age, with the first FDA approved...
Getting clinical trial endpoints defined correctly
As corporate commitment and cost to develop a treatment for any Rare Disease increases, the risk for smaller biotech companies and even...
FDA clears a new regulatory path for digital health device development
The FDA just put their Digital Health Action Plan into practice with the announcement of the nine companies chosen as part of their...
Driving digital innovation upstream to create value beyond the pill...and beyond an app.
As an industry, pharma is finding a seat at the digital table after being reluctant to join the digital health party with other...
Has healthcare shot itself in the foot with its pay-per-service addiction?
Healthcare's pay-per-service methodology has become an addiction, and one with very serious consequences for the industry. Physicians are...
What can we learn from the millions of new genes identified in the human microbiome?
A new microbiome study published in Nature called Strains, functions and dynamics in the expanded Human Microbiome Project enhances a...
9 simple steps to a healthier microbiome
When it comes to our microbiome, diversity is king according to experts such as @TimSpector. This simple article provides some practical...
Did you know there is a rare disease film festival?
I have to commend Bo Bigelow and Daniel DeFabio for their idea to start Disorder: The Rare Disease Film Festival.
As someone with a...
Alnylam to lead the way on a new class of pharmaceuticals
There is a lot of success to be had in the rare disease sector, with thousands of diseases anxiously awaiting a medication for their...
Who are 'pharma' in the future...?
…Pharma is probably not even the right label as companies from Google to Nestle to 23&Me look to disrupt the market.
The recent...
The "largest digital health company on earth" is known for its sportswear
In today’s “digital health” news we have learned that Under Armour is now the largest digital health and fitness company on earth. In...
Opportunity to contribute to microbiome research
If like me you are personally and/or professionally interested in the potential of our microbiome, then there is an opportunity to...
Collaborative Strategy
It is interesting to see the findings of a recent HBR article summarising 4 different archetypes to strategic decision making. As many...
The problem with p-values
There are growing concerns that much of the published research may be false...
What started as a provocative and thoughtful publication
Can we now blame our gut bacteria for those extra pounds?
More than 603 million adults and 107 million children (out of a global population of 7.5 billion) are obese, a report from the Institute...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net